SUP35/YDR172W Summary Help

Standard Name SUP35 (see Nomenclature conflict Note)
Systematic Name YDR172W
Alias GST1 , PNM2 1 , SAL3 , SUF12 , SUP2 , SUP36
Feature Type ORF, Verified
Description Translation termination factor eRF3, has a role in mRNA deadenylation and decay; altered protein conformation creates the [PSI(+)] prion that alters translational fidelity and results in a nonsense suppressor phenotype (2, 3, 4, 5 and see Summary Paragraph)
Also known as: [PSI] , [PSI(+)]
Name Description SUPpressor
Gene Product Alias eRF3
Chromosomal Location
ChrIV:808324 to 810381 | ORF Map | GBrowse
Gbrowse
Genetic position: 142.87 cM
Gene Ontology Annotations All SUP35 GO evidence and references
  View Computational GO annotations for SUP35
Molecular Function
Manually curated
Biological Process
Manually curated
Cellular Component
Manually curated
Classical genetics
conditional
Large-scale survey
null
reduction of function
Resources
368 total interaction(s) for 235 unique genes/features.
Physical Interactions
  • Affinity Capture-MS: 57
  • Affinity Capture-RNA: 4
  • Affinity Capture-Western: 34
  • Biochemical Activity: 2
  • Co-crystal Structure: 5
  • Co-localization: 2
  • Co-purification: 2
  • Protein-peptide: 1
  • Reconstituted Complex: 41
  • Two-hybrid: 18

Genetic Interactions
  • Dosage Growth Defect: 1
  • Dosage Lethality: 7
  • Dosage Rescue: 9
  • Negative Genetic: 35
  • Phenotypic Enhancement: 9
  • Phenotypic Suppression: 42
  • Positive Genetic: 82
  • Synthetic Growth Defect: 6
  • Synthetic Lethality: 2
  • Synthetic Rescue: 9

Resources
Expression Summary
histogram
Resources
Localization
Phosphorylation PhosphoGRID | PhosphoPep Database
Structure
Homologs
sequence information
ChrIV:808324 to 810381 | ORF Map | GBrowse
SGD ORF map
Genetic position: 142.87 cM
Last Update Coordinates: 2011-02-03 | Sequence: 1996-07-31
Subfeature details
Relative
Coordinates
Chromosomal
Coordinates
Most Recent Updates
Coordinates Sequence
CDS 1..2058 808324..810381 2011-02-03 1996-07-31
Retrieve sequences
Analyze Sequence
S288C only
S288C vs. other species
S288C vs. other strains
Resources
External Links All Associated Seq | Entrez Gene | Entrez RefSeq Protein | MIPS | Search all NCBI (Entrez) | UniProtKB
Primary SGDIDS000002579

NOMENCLATURE CONFLICT NOTE

NameRelevanceDescription
SUP2Nomenclature conflictSUP2 has been used to refer to both SUP35/YDR172W, which encodes a translation release factor, and SUP2/tY(GUA)D, which encodes tRNA-Tyr.
SUMMARY PARAGRAPH for SUP35

The [PSI+] prion determinant causes nonsense suppressor phenotype due to a reduced function of the translation termination factor Sup35p (eRF3) polymerized into amyloid fibrils. Prion state of the Rnq1 protein, [PIN+], is required for the [PSI+] de novo generation, but not propagation. Yeast [psi-] [PIN+] cells overproducing Sup35p can exhibit nonsense suppression without generation of a stable [PSI+]. In such cells most of Sup35p is present in amyloid polymers, though remaining Sup35p monomer is sufficient for normal translation termination. Presence of these polymers strictly depends on [PIN+], suggesting that their maintenance relies on efficient generation de novo, rather than inheritance. Sup35p polymers contain Rnq1p, confirming that Rnq1p polymers seed Sup35p polymerization (4).

Last updated: 2005-03-15

References cited on this page View Complete Literature Guide for SUP35
1) Doel SM, et al.  (1994) The dominant PNM2- mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137(3):659-70
2) Lindquist S, et al.  (2001) Investigating protein conformation-based inheritance and disease in yeast. Philos Trans R Soc Lond B Biol Sci 356(1406):169-76
3) Derkatch IL, et al.  (2004) Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci U S A 101(35):12934-9
4) Salnikova AB, et al.  (2005) Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J Biol Chem 280(10):8808-12
5) Funakoshi Y, et al.  (2007) Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases. Genes Dev 21(23):3135-48